F. Wurm, Production of recombinant protein therapeutics in cultivated mammalian cells, Nature Biotechnology, vol.57, issue.11, pp.1393-1398, 2004.
DOI : 10.1038/nbt1021

G. Walsh, Biopharmaceutical benchmarks 2014, Nature Biotechnology, vol.11, issue.10, pp.992-1000, 2014.
DOI : 10.4161/mabs.25864

D. Ghaderi, M. Zhang, N. Hurtado-ziola, and A. Varki, Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation, Biotechnology and Genetic Engineering Reviews, vol.9, issue.6, pp.147-175, 2012.
DOI : 10.5661/bger-28-147

L. Loureiro, M. Carrascal, A. Barbas, J. Ramalho, C. Novo et al., Challenges in Antibody Development against Tn and Sialyl-Tn Antigens, Biomolecules, vol.5, issue.3, pp.1783-1809, 2015.
DOI : 10.3390/biom5031783

URL : https://hal.archives-ouvertes.fr/hal-01221583

M. Cogné, S. Duchez, and V. Pascal, Transgen??se animale et humanisation des anticorps, m??decine/sciences, vol.25, issue.12, pp.1149-1154, 2009.
DOI : 10.1051/medsci/200925121149

D. Bellet and V. Dangles-marie, Anticorps humanis??s en th??rapeutique, m??decine/sciences, vol.21, issue.12, pp.1054-1062, 2005.
DOI : 10.1051/medsci/200521121054

W. Marasco and J. Sui, The growth and potential of human antiviral monoclonal antibody therapeutics, Nature Biotechnology, vol.49, issue.12, pp.1421-1434, 2007.
DOI : 10.1016/S0022-1759(99)00223-9

T. Olafsen and A. Wu, Antibody Vectors for Imaging, Seminars in Nuclear Medicine, vol.40, issue.3, pp.167-181, 2010.
DOI : 10.1053/j.semnuclmed.2009.12.005

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853948

A. Cuesta, N. Sainz-pastor, J. Bonet, B. Oliva, and L. Alvarez-vallina, Multivalent antibodies: when design surpasses evolution, Trends in Biotechnology, vol.28, issue.7, pp.355-362, 2010.
DOI : 10.1016/j.tibtech.2010.03.007

B. Kelley, Industrialization of mAb production technology: The bioprocessing industry at a crossroads, mAbs, vol.1, issue.5, pp.443-452, 2009.
DOI : 10.4161/mabs.1.5.9448

B. Paul, R. Jr, . Culture, . De-cellules-animales-dans-l-'industrie, . Pharmaceutique et al., Available from, pp.43-45

F. Wurm, Production of recombinant protein therapeutics in cultivated mammalian cells, Nature Biotechnology, vol.57, issue.11, pp.1393-1398, 2004.
DOI : 10.1038/nbt1021

Z. Jiang, K. , and Z. Geng, Fed-Batch Cell Culture Process Optimization A Rationally Integrated Approach Available from, BioProcess International [Internet], 2012.

P. Gronemeyer, R. Ditz, and J. Strube, Trends in Upstream and Downstream Process Development for Antibody Manufacturing, Bioengineering, vol.1, issue.4, pp.188-212, 2014.
DOI : 10.3390/bioengineering1040188

F. Li, N. Vijayasankaran, A. Shen, . Yijuan-), R. Kiss et al., Cell culture processes for monoclonal antibody production, mAbs, vol.26, issue.5, pp.466-479, 2010.
DOI : 10.1007/s10616-006-9004-9

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958569

F. Lu, P. Toh, I. Burnett, F. Li, T. Hudson et al., Automated dynamic fed-batch process and media optimization for high productivity cell culture process development, Biotechnology and Bioengineering, vol.55, issue.5, pp.191-205, 2013.
DOI : 10.1002/bit.24602

K. Talley and E. Alexov, On the pH-optimum of activity and stability of proteins, Proteins: Structure, Function, and Bioinformatics, vol.271, issue.Database issue, pp.2699-2706, 2010.
DOI : 10.1002/prot.22786

R. Castilho, A. Moraes, E. Augusto, and M. Butler, Animal Cell Technology: From Biopharmaceuticals to Gene Therapy, 2008.

A. Gigout, M. Buschmann, and M. Jolicoeur, The fate of Pluronic F-68 in chondrocytes and CHO cells, Biotechnology and Bioengineering, vol.14, issue.5, pp.975-987, 2008.
DOI : 10.1002/bit.21840

M. Zhu, A. Goyal, D. Rank, S. Gupta, V. Boom et al., Effects of Elevated pCO2 and Osmolality on Growth of CHO Cells and Production of Antibody-Fusion Protein B1: A Case Study, Biotechnology Progress, vol.55, issue.3, pp.70-77, 2005.
DOI : 10.1021/bp049815s

N. Kurano, C. Leist, F. Messi, S. Kurano, and A. Fiechter, Growth behavior of Chinese hamster ovary cells in a compact loop bioreactor. 2. Effects of medium components and waste products, Journal of Biotechnology, vol.15, issue.1-2, pp.113-128, 1990.
DOI : 10.1016/0168-1656(90)90055-G

A. Kandula, Harvest and Recovery of Monoclonal Antibodies from Large-Scale Mammalian Cell Culture [Internet] Available from: http://www.biopharminternational.com/harvest-and-recovery-monoclonal-antibodies- large-scale-mammalian-cell-culture

G. Quigley, Prefiltration in Biopharmaceutical Processes In: Filtration and Purification in the Biopharmaceutical Industry Available from, pp.1-219780849379543, 2007.

D. Roush and Y. Lu, Advances in Primary Recovery: Centrifugation and Membrane Technology, Biotechnology Progress, vol.24, issue.3, pp.488-495, 2008.
DOI : 10.1021/bp070414x

Y. Du, A. Walsh, R. Ehrick, W. Xu, K. May et al., Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies, mAbs, vol.122, issue.5, pp.578-585, 2012.
DOI : 10.1016/j.molimm.2010.12.009

. Leem, Bilan économique des Entreprises du Médicament -édition 2015

. Lonza, &. Protein, . Vaccine-development, and . Services, Design, Assess and Optimize for Clinical Success [Internet] Available from

A. Rathore and H. Winkle, Quality by design for biopharmaceuticals, Nature Biotechnology, vol.321, issue.1, pp.26-34, 2009.
DOI : 10.1038/nbt0109-26

F. Li, Y. Hashimura, R. Pendleton, J. Harms, E. Collins et al., A Systematic Approach for Scale-Down Model Development and Characterization of Commercial Cell Culture Processes, Biotechnology Progress, vol.22, issue.3, pp.696-703, 2006.
DOI : 10.1021/bp0504041

N. Singh, A. Arunkumar, S. Chollangi, Z. Tan, M. Borys et al., Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives, Biotechnology and Bioengineering, vol.6, issue.4, 2015.
DOI : 10.1002/bit.25810

I. Ich, . Tripartite, . Development, . Manufacture, . Of et al., Available from: http://www.ich.org/fileadmin/Public_Web_Site, p.91

C. Hakemeyer, Scale down models for cell culture [Internet]. 2013 Availa ble from